Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-05-10
1996-01-23
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514256, 514303, 514338, 544295, 544362, 544364, 544370, 544333, 544392, 546118, 546271, 5483097, 5483101, A61K 31495, A61K 31505, C07D40310, C07D40312
Patent
active
054865174
ABSTRACT:
Benzimidazoles and imidazopyridines are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and for the treatment of disorders which respond to dopaminergic blockade including psychotis depression, substance abuse, and compulsive disorders.
REFERENCES:
patent: 3985891 (1976-10-01), Kutter et al.
Kutter et al., Chemical Abstracts, vol. 82, No. 4251 (1974).
Hasegawa et al., Chemical Abstracts, vol. 75, No. 76797 (1971).
Kutter et al., Chemical Abstracts, vol. 83, No. 206270 (Abstract for DE 2,361,757 Jun. 26, 1975 (1975).
Downing Dennis M.
Glase Shelly A.
Johnson Stephen J.
Wise Lawrence D.
Wright Jonathan L.
Bernhardt Emily
Tinney Francis J.
Warner-Lambert & Company
LandOfFree
Benzimidazoles and imidazopyridines as central nervous system ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazoles and imidazopyridines as central nervous system ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazoles and imidazopyridines as central nervous system ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1505144